Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State | CNN
Teva plans to raise Mylan bid by as much as $2 billion: Bloomberg | Reuters
Teva Is Facing Adderall Supply Disruptions as Demand for ADHD Drug Soars - Bloomberg
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg
The Difficulties of Cloning a CEO - Bloomberg
Actavis CEO: Teva-Mylan deal could be "value-destroying" - גלובס
A bottle of Teva Pharmaceutical Industries Ltd. Clonazepam medication... News Photo - Getty Images
Teva Pharma's Short Sellers Double Down as Legal Woes Drag On - BNN Bloomberg
Teva flags supply constraints to ADHD drug Adderall as demand rises (NYSE: TEVA) | Seeking Alpha
Teva Considering Cutting up to 10,000 Jobs: Bloomberg
ADHD Drug Adderall Supply Delays Likely to Continue for 2-3 Months, Teva Says - Bloomberg
Future Teva CEO Seeks to 'Formulate Clear Strategy' - YouTube
Teva CEO Resigns; Dividend Cut Should Be Next - Bloomberg
Teva looks to sell generics in China through joint venture with Guangzhou Pharma: Bloomberg | Fierce Pharma
Teva Analysts Say Migraine Drug Approval Gives Needed Relief - Bloomberg
Teva CEO Kare Schultz Says Drugmaker Will Fight US Price-Fixing Charges - Bloomberg
Teva Sees Adderall Supply Delays Continuing for 2-3 Months (1)
Teva Pharmaceutical Will Pay Over $4 Billion in Opioid Settlement - Bloomberg
Teva (TEVA) Agrees to $225 Million Texas Opioid Settlement, AG Says - Bloomberg
Tags search | Ctech
Teva, Units Held Liable for Fueling N.Y. Opioid Crisis - Bloomberg
Teva Pharma's Short Sellers Double Down as Legal Woes Drag On - Bloomberg
